Across NYSORA’s global events one theme consistently emerges: clinicians want to see real innovation. They want to understand not just the science, but the tools and technologies reshaping regional anesthesia, pain management, and perioperative care.
That’s why NYSORA continues to support non-CME lunch break presentations for industry partners. These short sessions give companies a high-visibility moment to showcase new technologies, tools, and ideas directly to an audience that’s hungry for practical solutions.
This initiative aligns with a long-standing NYSORA vision:
to bring clinicians and innovators into the same room, spark meaningful dialogue, and showcase the adoption of safer evidence-based technologies.
A Proven Example: Medasense & the NOL Index
One of the most impactful industry spotlights at our events has been the presentation by MedaSense Biometrics, the company behind the AI-driven Nociception Level (NOL) Index®.
Traditionally, assessing nociception during anesthesia has been subjective and inconsistent. Medasense’s NOL technology introduces a new level of precision. It uses a combination of physiological signals-photoplethysmography (PPG), galvanic skin response, peripheral temperature changes, and motion – to generate a single, personalized NOL value.
In practice, this gives clinicians:
- A clearer, continuous picture of a patient’s nociception level
- Better insight into block effectiveness
- A data-driven way to titrate analgesics
- Reduced risk of both under- and over-treating pain
- More consistent, predictable outcomes
The PMD-200™ monitor, built around the NOL Index, has been recognized as one of the first tools to bring true objectivity into intraoperative nociception monitoring. Its ability to guide analgesia with precision aligns perfectly with the growing focus on individualized anesthesia care, opioid optimization, and safety.
At our recent New York event, Pascal Laferriere-Langlois delivered a compelling lunch-time session titled:
“Innovation in Regional Anesthesia: Introducing the AI-driven NOL Index for Precision Pain Management.”
His session demonstrated exactly what these lunch break presentations are meant to achieve:
showcasing a technology that is scientifically grounded, clinically relevant, and immediately useful in practice.
He highlighted real-world applications, explained how the NOL Index can validate block success, and showed how AI-driven monitoring fits into modern regional anesthesia workflows. Clinicians responded with practical questions and enthusiastic engagement.
Watch the video snippet below:
View this post on Instagram
Benefits of NOL Monitoring in Regional Anesthesia
Clinical studies have shown that NOL monitoring can:
- Quantify the effectiveness of regional blocks
- Support personalized opioid dosing
- Provide an objective measure of nociception–antinociception balance
- Reduce variability in opioid administration
- Enhance patient safety by minimizing both under- and over-medication
- Support recovery with more personalized and balanced analgesia
Together, these benefits allow anesthesiologists to move beyond subjective interpretation toward a more precise, patient-specific approach.
Bridging Innovation and Clinical Practice
NYSORA’s mission has always been simple:
bring the best knowledge and the best tools to the people who care for patients.
Industry lunch sessions help make that possible.
They connect innovators with clinicians, spark meaningful conversations, and highlight solutions that can genuinely improve clinical practice.
If you’re interested in being featured, contact us at [email protected].
And don’t miss your chance to join us – explore our upcoming events!
